Base +1 yr-Renewal A1C Hemoglobin Controls-Reagents wth HGB Analyzer

Pursuant to FAR Subpart 13.106-1(b) (1), the U.S. Army, MEDCOM, Regional Health Contracting Office-Pacific Joint Base Lewis-McChord, Health Contracting Branch, Lacey, WA, intends to issue a sole source firm-fixed price award under solicitation W81K0220Q0242 to Sebia Inc in the amount of $190,000.00 for a Base + 1 year Option period on renewal of A1C Hemoglobin Controls, Reagents, and Consumables, to include Trade-In of Sebia Capillary 2 Electrophoresis Analyzer, for the Sebia Capillary 3, for Pathology Department at Madigan Army Medical Center Tacoma WA, Sebia Inc., fully capable of performing automated Hemoglobin Electrophoresis, Serum Protein Electrophoresis, Serum Immunotyping, Urine Protein Electrophoresis, Carbohydrate Deficient Transferrin (CDT), and Hemoglobin A1C, which represents the only compatible source proprietary to usage of their reagents and supplies,  and meets the customer salient characteristics in providing automated testing results in accomplishing the mission.

This notice is not a request for proposal and a solicitation will not be issued.   Any vendor that believes it can provide the stated supplies/equipment can provide supporting documentation demonstrating their products capability and specifications.  Responses received will be used in consideration of future acquisitions.  Information can be sent to the Purchasing Agent; Mr. Walter J. Bischoff, email; walter.j.bischoff.civ@mail.mil .  No telephone or facsimile requests will be accepted.  This procurement will be prepared in accordance with FAR Part 13, using Simplified Acquisition Procedures.